US 11542338
CD38 modulating antibody
granted A61KA61K2039/505A61K2039/627
Quick answer
US patent 11542338 (CD38 modulating antibody) held by BLACK BELT THERAPEUTICS LIMITED expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BLACK BELT THERAPEUTICS LIMITED
- Grant date
- Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K2039/627, A61K39/395, A61P